Hybrid nanoreservoirs based on dextran‐capped dendritic mesoporous silica nanoparticles for CD133‐targeted drug delivery
- 5 July 2019
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 235 (2) , 1036-1050
Abstract
In this study, the chemical features of dendritic mesoporous silica nanoparticles (DMSNs) provided the opportunity to design a nanostructure with the capability to intelligently transport the payload to the tumor cells. In this regard, doxorubicin (DOX)‐encapsulated DMSNs was electrostatically surface‐coated with polycarboxylic acid dextran (PCAD) to provide biocompatible dextran‐capped DMSNs (PCAD‐DMSN@DOX) with controlled pH‐dependent drug release. Moreover, a RNA aptamer against a cancer stem cell (CSC) marker, CD133 was covalently attached to the carboxyl groups of DEX to produce a CD133‐PCAD‐DMSN@DOX. Then, the fabricated nanosystem was utilized to efficiently deliver DOX to CD133+ colorectal cancer cells (HT29). The in vitro evaluation in terms of cellular uptake and cytotoxicity demonstrated that the CD133‐PCAD‐DMSN@DOX specifically targets HT29 as a CD133 overexpressed cancer cells confirmed by flow cytometry and 3‐(4,5‐dimethyl‐2‐thiazolyl)‐2,5‐diphenyl‐2‐H‐tetrazolium bromide assay. The potentially promising intelligent‐targeted platform suggests that targeted dextran‐capped DMSNs may find impressive application in cancer therapy.Keywords
Funding Information
- Mashhad University of Medical Sciences
This publication has 48 references indexed in Scilit:
- Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine deliveryNanoscale, 2013
- Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticlesBiomaterials, 2012
- SN-38 loaded polymeric micelles to enhance cancer therapyNanotechnology, 2012
- G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicityJournal of Controlled Release, 2011
- Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibilityJournal of Materials Chemistry, 2011
- Preparation and in vitro evaluation of actively targetable nanoparticles for SN-38 delivery against HT-29 cell linesNanomedicine: Nanotechnology, Biology and Medicine, 2010
- Dose- and time-dependent effects of doxorubicin on cytotoxicity, cell cycle and apoptotic cell death in human colon cancer cellsToxicology, 2010
- Ordered mesoporous materials in catalysisMicroporous and Mesoporous Materials, 2005
- Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cellsOncogene, 2004
- Caspase inhibition switches doxorubicin-induced apoptosis to senescenceOncogene, 2003